Allen Sariah J, Mott Kevin R, Ghiasi Homayon
Department of Surgery, CSMC Burns & Allen Research Institute, Center for Neurobiology and Vaccine Development, Ophthalmology Research Laboratories, Los Angeles, CA 90048, USA.
Mol Vis. 2010 Jan 26;16:98-104.
To assess the relative impact of elevated T-helper 2 (T(H)2)- and reduced T-Helper 1 (T(H)1)-dependent immune responses on ocular herpes simplex virus type 1 (HSV-1) infection.
Signal transducer and activator of transcription protein 4 knockout mice (BALB/c-STAT4(-/-)) and wild-type BALB/c control mice were immunized with avirulent HSV-1 strain KOS or were mock-immunized. Three weeks after the third immunization, neutralizing antibody titers were determined by plaque reduction assays. Following ocular infection with virulent HSV-1 strain McKrae, viral replication in the eye, blepharitis, corneal scarring (CS), survival, and immunoglobulin (Ig) isotypes in sera were determined.
Vaccinated STAT4(-/-) and BALB/c mice contained significant and similar neutralizing antibody titers and were completely protected against HSV-1-induced death and CS. In contrast to vaccinated STAT4(-/-) mice, mock-vaccinated STAT4(-/-) mice had higher ocular HSV-1 titers than mock-vaccinated BALB/c mice on days 2-3 post-ocular infection. There were also significant differences in the levels of IgG2a, IgG2b, and IgG3 in the sera of STAT4(-/-) mice when compared to the control BALB/c mice.
These results suggest that the absence of T(H)1 cytokine responses did alter protection against viral replication and IgG isotypes but not eye disease or survival.
评估辅助性T细胞2(T(H)2)升高和辅助性T细胞1(T(H)1)依赖性免疫反应降低对单纯疱疹病毒1型(HSV-1)眼部感染的相对影响。
用无毒力的HSV-1毒株KOS免疫信号转导和转录激活蛋白4基因敲除小鼠(BALB/c-STAT4(-/-))和野生型BALB/c对照小鼠,或进行假免疫。第三次免疫三周后,通过蚀斑减少试验测定中和抗体滴度。在用强毒力的HSV-1毒株McKrae进行眼部感染后,测定眼部的病毒复制、睑缘炎、角膜瘢痕形成(CS)、存活率以及血清中的免疫球蛋白(Ig)同种型。
接种疫苗的STAT4(-/-)小鼠和BALB/c小鼠具有显著且相似的中和抗体滴度,并完全受到保护,免受HSV-1诱导的死亡和CS。与接种疫苗的STAT4(-/-)小鼠相比,在眼部感染后第2 - 3天,假接种的STAT4(-/-)小鼠的眼部HSV-1滴度高于假接种的BALB/c小鼠。与对照BALB/c小鼠相比,STAT4(-/-)小鼠血清中IgG2a、IgG2b和IgG3的水平也存在显著差异。
这些结果表明,缺乏T(H)1细胞因子反应确实改变了对病毒复制和IgG同种型的保护,但未改变眼部疾病或存活率。